Other Cancer Types

Anal

Meetings of the Minds

BY CHARLOTTE HUFF

What is multidisciplinary care, and where can patients get it? 

Bladder

Renaissance Surgery

BY BEVERLY A. CALEY

Using robotic arms, video cameras, and tiny incisions, cancer surgeons are changing what it means to go under the knife.

Bladder

Under New Management

BY PAUL ENGSTROM

Newer and better supportive care days to control side effects are making treatments easier for patients. 

Bladder

Bladder Cancer: Breaking the Research Barrier

BY BEVERLY A. CALEY

Cervical

The HPV Debate

EDITED BY ELIZABETH WHITTINGTON

Texas becomes the first state to require HPV vaccination, while other states are debating to mandate the vaccine as well.

Cervical

Renaissance Surgery

BY BEVERLY A. CALEY

Using robotic arms, video cameras, and tiny incisions, cancer surgeons are changing what it means to go under the knife.

Cervical

Under New Management

BY PAUL ENGSTROM

Newer and better supportive care days to control side effects are making treatments easier for patients. 

Esophageal

Deadly Accuracy

BY KATY HUMAN

Proton beam therapy kills cancer cells without the collateral damage of traditional radiation.

Esophageal

Under New Management

BY PAUL ENGSTROM

Newer and better supportive care days to control side effects are making treatments easier for patients. 

Gastric

Gut Reaction

BY KAREN PATTERSON

A breast cancer drug delivers a heavy blow to certain stomach cancers. 

Gastric

Treatment Updates

BY SUSAN PECK, PHD

Treatment updates from the 2009 ASCO Gastrointestinal Cancers Symposium.

Gastrointestinal stromal tumor

Rash Decisions

BY MELISSA WEBER

Educational campaign launched to help nurses help patients who have treatment-related rash. 

Gastrointestinal stromal tumor

Meetings of the Minds

BY CHARLOTTE HUFF

What is multidisciplinary care, and where can patients get it? 

Kidney

Reining in Renal Cancer

BY KAREN PATTERSON

Are we closer to treating advanced kidney cancer as a chronic disease?

Kidney

Kidney Cancer Expert Shares Insight on New Therapies

BY MELISSA WEBER

New therapies are making headway in a difficult-to-treat cancer. 

Kidney

Picking Up Momentum for Treating Renal Cell Carcinoma

BY BEVERLY A. CALEY

Advanced treatments take form for a notoriously hard-to-beat cancer.

Kidney

Renaissance Surgery

BY BEVERLY A. CALEY

Using robotic arms, video cameras, and tiny incisions, cancer surgeons are changing what it means to go under the knife.

Kidney

Gaining an Edge Against Cancer

BY ELIZABETH WHITTINGTON

Cancer research pushes forward as scientists find creative ways to attack cancer.

Kidney

Breaking News from ASCO

BY STAFF REPORTS

Updates from the 2008 annual meeting of the American Society of Clinical Oncology includes news on lung, breast, colorectal, and kidney cancers.

Kidney

Kidney Cancer & Lung Cancer

BY ELIZABETH WHITTINGTON

New therapy available for renal cell carcinoma and first maintenance therapy is approved for lung cancer. 

Kidney

Kidney Cancer & Prostate Cancer

BY ELIZABETH WHITTINGTON

The FDA approves third kidney cancer drug and blood-clotting therapy while delaying review on a prostate cancer vaccine, and one drug edges another in a colorectal cancer clinical trial.

Kidney

Rash Decisions

BY MELISSA WEBER

Educational campaign launched to help nurses help patients who have treatment-related rash. 

Liver

The Internal Flame

BY KAREN PATTERSON

Chronic inflammation causes cancer. Find out how and what's being done about it. 

Liver

Liver Cancer: More Cases, More Causes

BY JENNIFER M. GANGLOFF

The incidence of the most common type of liver cancer, known as hepatocellular carcinoma, has been on the rise in recent decades—and researchers know why.  

Liver

Liver Cancer: A Global Epidemic

A worldwide view of liver cancer incidence.

Liver

Breast Cancer, Liver Cancer & Leukemia

BY ELIZABETH WHITTINGTON

Recent drug approvals yield a new chemotherapy agent, a first for liver cancer, a safer prevention method, and good news for a drug-resistant cancer.  

Liver

Breast Cancer & Liver Cancer

BY ELIZABETH WHITTINGTON

An approval in breast cancer, positive clinical trial results in liver cancer, while a prostate cancer drug disappoints. 

Liver

Web Exclusive: Can Liver Cancer Be Found Early?

BY THE AMERICAN CANCER SOCIETY

While liver cancer is typically hard to diagnosis, and usually found in its later stages, there are ways to be proactive about screenings and know your risk. 

Liver

Gaining an Edge Against Cancer

BY ELIZABETH WHITTINGTON

Cancer research pushes forward as scientists find creative ways to attack cancer.

Liver

Under New Management

BY PAUL ENGSTROM

Newer and better supportive care days to control side effects are making treatments easier for patients. 

Liver

Rash Decisions

BY MELISSA WEBER

Educational campaign launched to help nurses help patients who have treatment-related rash. 

Myelodysplastic syndrome

Medicine's New Epicenter? Epigenetics

BY LAURA BEIL

Flipping cancer's "off" switch.

Myelodysplastic syndrome

Treatment Boost for MDS

BY ALICE MCCARTHY

Deep in the bone marrow lies the reason for blood disorders classified as myelodysplastic syndromes—stem cells gone awry.

Myelodysplastic syndrome

Prostate Cancer & MDS

BY ELIZABETH WHITTINGTON

Satraplatin's approval review deadline gets pushed back by the FDA and a large clinical trial shows Vidaza extends  survival in patients with MDS.

Myeloma

Treatment Updates

BY STAFF REPORTS

Updates from the American Society of Hematology meeting and the San Antonio Breast Cancer Symposium.

Myeloma

Progress in Treating Multiple Myeloma

BY PETER WEST

The old and the new in myeloma therapy give patients more options.

Myeloma

Researchers and Advocates Make Progress in Multiple Myeloma

BY ELIZABETH WHITTINGTON

Brian Durie, MD, and Susan Novis, president of the International Myeloma Foundation, answer questions about the progress in multiple myeloma.

Myeloma

Blood Cancers Meeting Stresses the Importance of Clinical Trials

BY LACEY MEYER

Clinical trials and other relevant topics were highlighted at the 2009 Texas Forum on Blood Cancers.

Myeloma

Precious Tumor

BY CHARLOTTE HUFF

What happens to cancer tissue and why it's so valuable to researchers.

Myeloma

Cell Restoration

BY ROBERT S. DINSMOOR

Stem cell transplantation is safer and more accessible than ever before. 

Myeloma

Multiple Myeloma & Leukemia

BY ELIZABETH WHITTINGTON

Drugs for multiple myeloma and CML reach patients. 

Myeloma

Multiple Myeloma & Thrombocytopenia

BY ELIZABETH WHITTINGTON

Velcade is now available for newly diagnosed multiple myeloma patients and new drugs emerge as potential treatment to a serious side effect. 

Myeloma

Lymphoma, Myeloma & Prostate Cancer

BY ELIZABETH WHITTINGTON

FDA approves Mozobil for non-Hodgkin lymphoma and myeloma, and Degarelix for advanced prostate cancer. 

Pancreatic

Rash Decisions

BY MELISSA WEBER

Educational campaign launched to help nurses help patients who have treatment-related rash. 

Pancreatic

House Call

BY HENRY Q. XIONG, MD, PHD

The new drug for pancreatic cancer and other treatments being tested.

Sarcoma

The New Sarcoma Story

BY BEVERLY A. CALEY

Strategies for diagnosing and treating sarcomas shift to a more patient-specific approach.

Sarcoma

Secondary Sarcomas

BY BEVERLY A. CALEY

Some cancer therapies can increase the risk of secondary cancers such as sarcoma, especially for childhood cancer survivors.

Sarcoma

Web Exclusive: Types of Sarcoma

BY THE NATIONAL CANCER INSTITUTE

While sarcomas can be divided into soft-tissue or bone sarcomas, there are about 600 different types of sarcomas patients can be diagnosed with. 

Sarcoma

Dealing With Disfigurement

BY MEGAN KINKADE

Fewer sarcoma patients are facing limb amputation with limb-salvaging surgery, but for survivors like Joshua Isaac, physical and emotional rehabilitation can help.  

Sarcoma

Hazardous to Your Heart

BY JAMIE SPENCER

Protecting the heart from toxic side effects of cancer therapy.

Testicular

Having a Ball

EDITED BY ELIZABETH WHITTINGTON

Testicular cancer survivor Bob Hammer and his Have a Ball Foundation. 

Thyroid

The Good Cancer?

BY CHARLOTTE HUFF

Thyroid cancer's high survival rate masks the sometimes tricky tumor. 

Unknown primaries

No I.D.

BY KATY HUMAN

Treating cancer is a tricky matter when the type is unknown.

Unknown primaries

Meetings of the Minds

BY CHARLOTTE HUFF

What is multidisciplinary care, and where can patients get it? 

Unknown primaries

No I.D.

BY KATY HUMAN

Treating cancer is a tricky matter when the type is unknown.

Unknown primaries

Meetings of the Minds

BY CHARLOTTE HUFF

What is multidisciplinary care, and where can patients get it?